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Abst rac t
Background and purpose: Patients suffering from Hunting-
ton disease (HD) have been shown to present with poor self-
awareness of a variety of symptoms. The study aimed to assess
the self-awareness of memory impairment in HD in compa-
rison to advanced Parkinson disease (PD), mild PD and
cervical dystonia. 
Material and methods: Self-awareness was tested in 23 pa -
tients with HD by comparing patient and caregiver ratings
in reference to clinical control groups (25 patients with advan-
ced PD, 21 with mild PD and 20 with cervical dystonia).
Self-awareness was tested using the Self Rating Scale of Me -
mory Functions, which was administered to both the patients
and the caregivers. Neuropsychological assessment addres-
sed general cognitive status (Mini-Mental State Examina-
tion), verbal learning (Auditory Verbal Learning Test, 15-word
list) and mood (Montgomery-Asberg Depression Rating 
Scale).
Results: Patients with HD significantly underestimated their
memory dysfunction. Underestimation of memory deficit cor-
related with disease duration and disease severity in HD.
Conclusions: Huntington disease patients underestimate me -
mory dysfunction. These results add to the previous reports
on poor insight in HD in other domains and suggest that ano-
sognosia in HD, albeit usually rather mild, may be a genera -
lized phenomenon.
Key words: Huntington disease, verbal learning, awareness.
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Wstêp i cel pracy: U pacjentów z chorob¹ Huntingtona (ChH)
stwierdza siê zaburzon¹ samoœwiadomoœæ wielu objawów.
Badanie mia³o na celu ocenê samoœwiadomoœci zaburzeñ
pamiêci u chorych na ChH w porównaniu z chorymi na
zaawansowan¹ chorobê Parkinsona (ChP), ChP z niewiel-
kim nasileniem objawów oraz chorymi na dystoniê szyjn¹. 
Materia³ i metody: Samoœwiadomoœæ zaburzeñ pamiêci zba-
dano u 23 chorych na ChH poprzez porównanie ocen pacjen-
tów i opiekunów w odniesieniu do klinicznych grup porów-
nawczych (25 chorych na zaawansowan¹ ChP, 21 chorych na
ChP z niewielkim nasileniem objawów oraz 20 chorych na
dystoniê szyj n¹). Samoœwiadomoœæ zaburzeñ pamiêci zbada-
no przy u¿yciu skali Samooceny funkcjonowania pamiêci (Self
Rating Scale of Memory Functions), któr¹ wype³niali zarówno
pacjenci, jak i opiekunowie. W badaniu neuropsychologicz-
nym oceniano ogólny stan funkcjonowania poznawczego
(Mini-Mental State Examina tion), uczenie siê materia³u s³ow -
nego (Audi tory Verbal Learning Test, lista 15 s³ów) oraz nastrój
(Montgomery-Asberg Depression Rating Scale). 
Wyniki: Chorzy na ChH nie byli w stanie w³aœciwie oceniæ
nasilenia zaburzeñ pamiêci, uwa¿aj¹c, ¿e funkcjonuje ona
lepiej, ni¿ to by³o w rzeczywistoœci. Tendencja ta korelowa³a
z czasem trwania choroby oraz nasileniem jej objawów.
Wnioski: Chorzy na ChH nie zdaj¹ sobie w pe³ni sprawy z na -
silenia zaburzeñ pamiêci. Uzyskane wyniki wspieraj¹ wczeœ -
niejsze doniesienia z piœmiennictwa o zaburzonym wgl¹dzie
w ChH dotycz¹cym wielu sfer funkcjonowania i sugeruj¹, ¿e
anozognozja w ChH, aczkolwiek zazwyczaj raczej ³agodna,
mo¿e mieæ charakter uogólniony.
S³owa kluczowe: choroba Huntingtona, uczenie siê materia³u
s³ownego, œwiadomoœæ.
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Introduction
Huntington disease (HD) is an autosomal dominant
inherited neurodegenerative disorder characterized by
motor, psychiatric and cognitive symptoms [1,2]. Slight
cognitive impairment usually affects individuals at the pre-
clinical stage of the disease, a few years before the onset
of motor symptoms [3]. Executive deficits and working
memory impairment predominate in the cognitive pro-
file of HD. However, episodic memory and spatial func-
tion are also significantly affected [2,4,5]. 
Memory deficits in HD concern declarative memo-
ry (“know what” – this type of memory refers to both
episodic and semantic memory) [4,6] and non-declara -
tive memory (“know how”, procedural memory among
other things) [7-9]. Episodic memory deficits may ap -
pear relatively early, even at the preclinical stage [10].
More specifically, temporal order memory deficits are
observed in asymptomatic gene carriers [11]. At more
advanced disease stages, it can be observed that the ret-
rograde amnesia in HD does not follow the temporal gra-
dient, typical for Alzheimer disease (AD), where infor-
mation from the remote past is much better recalled than
recent events [12]. In HD it makes an interview with the
patient rather difficult, as the patient usually cannot recall
many facts (e.g. childhood diseases) or put them in the
correct chronological order. Another specific feature of
memory impairment in HD is the difficulty with recall-
ing the spatial localization of objects. In contrast to AD,
HD patients recall the object better than its spatial local-
ization [13]. 
Tasks assessing episodic memory (delayed recall mea-
sures from Wechsler Memory Scale and most scores from
California Verbal Learning Test, CVLT) are particular-
ly sensitive in detecting cognitive impairment in HD
[14]. Results of verbal learning assessment in HD using
the CVLT, Hopkins Verbal Learning Test (HVLT) and
Rey Auditory Verbal Learning Test (RAVLT) reveal a pat-
tern typical for subcortical dementia: low learning cur -
ve, slight problems with delayed recall, and marked im -
provement in cued recall or in recognition trials [15,16].
HD patients may not be fully aware of the presence
or severity of a variety of symptoms: (a) motor (mainly
chorea) [17-19], (b) disability in the activities of daily
living [20,21], (c) emotional problems [21,22], and (d)
executive dysfunction [23]. Inadequate self-report of one’s
function may even precede the clinical diagnosis of HD
[24]. To our knowledge, none of the previous studies have
addressed self-awareness of memory impairment in HD.
The present study aimed to assess insight into memory
impairment in patients with HD through the compari-
son with patients with advanced Parkinson disease (PD),
mild symptoms of PD, and patients with cervical dys-
tonia. The clinical comparison groups were chosen be -
cause of the common clinical characteristics in terms of
mood and motor symptoms (high prevalence of depres-
sion, the presence of involuntary movements evident to
a neurologically-naïve observer, possibly leading to stig-
ma) and the differences in the cognitive status. In or der
to exclude the influence of general cognitive status on the
patients’ ratings, the advanced PD group was matched
to the HD group according to Mini-Mental State Exam-
ination (MMSE) scores [25]. The group with mild PD
was chosen as it was supposed to have less impaired mem-
ory than the HD and advanced PD groups (in terms of
learning efficiency and delayed recall). Cervical dysto-
nia was chosen as a reference group as this disease does
not lead to cognitive impairment, but this patient group
shares some emotional and motor problems with HD and
PD, as mentioned before. What is more, only this group
could be matched to the HD group in terms of age, with-
out a selection bias. The cervical dystonia group was cho-
sen instead of a healthy control group so as to enable match-
ing of this group to the HD group in terms of mood. 
The assessment of self-awareness in neurodegene rative
disorders is performed using one or more of the follow-
ing types of measurement: clinician rating methods, ques-
tionnaire-based methods, performance-based methods,
phenomenological methods or multidimensional/com-
bined methods [26]. In the present study, we decided to
use combined methods: patient-caregiver comparison and
the comparison of subjective ratings against the objec-
tive criterion (memory test performance). Previous stu -
dies analysing self-awareness in HD used either only clin-
ician rated methods [20], patient-caregiver comparison
[23] or a performance-based method [18] in isolation
or, most commonly, using a combined approach [17,19,
21,22]. Only patient-caregiver comparison of the pa tient’s
memory function was performed in this study (without
control assessment of patients’ ratings of collaterals’ func-
tion) as previous studies demonstrated clearly that the
judgement deficit in HD concerns only rating one’s own
abilities and not others’ [21,23]. 
The study assessed the concordance of patients and
caregivers in reference to the patients’ memory and the
concordance of both patients’ and caregivers’ ratings with
the objective criterion of scores obtained in the memo-
ry testing. It was hypothesized that the HD patients would
underestimate memory impairment, both with reference
to caregivers’ ratings and to objective performance. 
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Material and methods
Patients
Eighty-nine patients from the Movement Disorders
Clinic (St. Adalbert Hospital, Gdansk, Poland) partici -
pated in the study (23 with HD, 25 with advanced PD,
21 with mild PD and 20 with cervical dystonia). The pa -
tients were diagnosed according to the established cli nical
criteria for HD [1], PD [27] and cervical dystonia [28].
Other diagnoses were excluded by neuro imaging (com -
puted tomography or magnetic resonance imaging) and
laboratory testing. In HD patients, the clinical diagno-
sis was confirmed by genetic testing. The main inclusion
criterion was MMSE score ≥ 20, which enabled further
neuropsychological and questionnaire assessment.
Patients with concurrent neurological disorders, with a his-
tory of alcohol abuse, with severe (oculo)motor impair-
ment (unable to stay in a sitting position for an hour and/or
unable to read), and those who did not have a caregiv-
er willing to participate, spending most of the time with
the patient and having known him/her prior to the dis-
ease onset, were excluded from the study. The word care-
giver was consequently used in the whole paper to refer
to the patient’s proxies, who in the case of some patients
(with PD and cervical dystonia) were not caregivers, but
just companions.
Demographic and clinical data are presented in
Table 1. The groups were matched in terms of sex and
Patients with HD Patients with Patients with mild PD Patients with P-value for
N = 23 advanced PD N = 21 cervical dystonia differences
N = 25 N = 20 between 
[A] [B] [C] [D] groups 
Age [years], mean ± SD 49.83 ± 11.12 65.68 ± 10.03 64.67 ± 7.59 51.75 ± 12.98 p < 0.001*
A vs. B, A vs. C, 
B vs. D, C vs. D
Education [years], median 12 12 13 12 0.57**
Sex ratio [men/women] 14/9 12/13 15/6 8/12 0.18***
Disease duration [years], 5 12 4 8 < 0.0001**
median A vs. B, B vs. C
Unified Parkinson’s Disease – 22.04 ± 9.14 18.29 ± 10.38 – 0.20†
Rating Scale – part III
score [pts], mean ± SD 
Daily levodopa dose [mg], median – 1000 500 – 0.002‡
Unified Huntington’s Disease 38.09 ± 14.33 – – – –
Rating Scale – motor score 
[pts], mean ± SD
Toronto Western Spasmodic – – – 15.55 ± 6.41 –
Torticollis Rating Scale – severity
score [pts], mean ± SD
Schwab-England Scale score NA 70 90 NA < 0.00001‡
[pts], median
Unified Huntington’s Disease 76.30 ± 11.40 NA NA NA NA
Rating Scale – independence score
[pts], mean ± SD 
Montgomery-Asberg Depression 10 15 7 10.5 0.0094**
Rating Scale [pts], median B vs. C
Table 1. Clinical and demographic data of patients with Huntington disease (HD), advanced Parkinson disease (PD), mild PD and cervical dystonia
SD – standard deviation; NA – not assessed
*One-way analysis of variance with post-hoc Scheffe test
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education. Due to the differences in the average age of
onset (usually late in PD, very variable in HD and cer-
vical dystonia but most often earlier in these groups 
than in PD) and the onset of cognitive impairment (ear-
ly in HD and rather late in PD), the groups could not
be matched in terms of age. Only HD and cervical dys-
tonia groups did not differ in terms of age. Huntington
disease and advanced PD groups were matched in terms
of general cognitive status according to the MMSE 
[t (46) = –0.52; p = 0.60]. Mood was significantly low-
er in advanced PD than in mild PD. All HD patients
were treated with neuroleptics (sulpiride, n = 14;
tiapride, n = 6; haloperidol, n = 4; chlorprothixene,
n = 1), and some of them took antidepressants (n = 19),
muscle relaxants (n = 1) and benzodiazepine derivatives
(n = 2). In the advanced PD group, the patients were treat-
ed with levodopa (n = 25), dopamine agonists (n = 18),
amantadine (n = 11), antidepressants (n = 6), benzo-
diazepine derivatives (n = 3) and acetylcholinesterase
inhibitors (n = 3). In the mild PD group, the patients
were treated with levodopa (n = 20), dopamine agonists
(n = 14), amantadine (n = 7), antidepressants (n = 4)
and selegiline (n = 3). All patients with cervical dysto-
nia received bo tulinum toxin injections, and one of them
was additionally treated with muscle relaxants. 
Methods
The questionnaires were filled in independently by
the patients and the caregivers. The patients provided self-
ratings of memory prior to the neuropsychological as sess-
ment. PD patients were always tested in the ‘on’ phase.
The study protocol was approved by the Medical Uni-
versity of Gdansk Bioethics Committee. The protocol was
in accordance with the Helsinki Declaration.
Neurological assessment
Neurological assessment comprised the Motor
Assessment and Independence Scale from the Unified
Huntington’s Disease Rating Scale (UHDRS) [29] in
HD, part III from the Unified Parkinson’s Disease Rat-
ing Scale (UPDRS) and the Schwab-England Scale [30]
in PD and the Toronto Western Spasmodic Torticollis
Rating Scale (TWSTRS) [31] in cervical dystonia. 
Neuropsychological assessment
Neuropsychological assessment comprised general cog-
nitive status testing (MMSE) [25] and verbal learn ing
testing using modified 15-word list learning (Auditory
Verbal Learning Test: AVLT) [32], devised by the au -
thors (E.J.S. and D.W.) [33]. The following measures
were analysed: the sum of words recalled in 5 learning
trials (max. 75), corrected recognition score (true posi-
tive recognitions minus false positive recognitions (max.
15), number of words recalled over delay (max. 15), per-
centage of words recalled after delay (number of words
recalled in the delayed recall trial divided by the average
of the two highest scores from immediate recall) and 
corrected delayed recognition score (true positive recog-
nitions minus false positive recognitions, max. 15). 
The pa tients’ mood was assessed by means of the Mont-
go mery-Asberg Depression Rating Scale (MADRS)
[34], which is filled in by the examiner and not the patient,
in order to avoid the influence of poor insight in HD on
the depression scores. 
Assessment of self-awareness of symptoms
The questionnaire memory assessment was perform-
ed by the patient and the caregivers using the adapted
Self-Rating Scale of Memory Functions (SRSMF) [35].
The questionnaire comprises 18 items with ratings
from 1 to 5. The final score, which is the summation of
item scores, ranges from 18 to 90, where the higher score
indicates more severe memory impairment. The Polish
version of the scale was adapted for both the patient [36]
and the caregiver [37]. After the testing, two measures
of patient-caregiver agreement were computed apart from
the raw scores. For each patient-caregiver pair, an aver-
age absolute patient-caregiver difference score (AADS)
was computed on the basis of all items, in order to assess
the disagreement, regardless of its direction: underesti-
mation or overestimation of impairment by the patients
[21]. Subsequently, on the basis of items in which the
patients assessed their memory function as better than the
caregiver, the underestimation score (US) was comput-
ed [37].
Statistical analysis
Normality of distribution was tested with Shapiro-Wilk
W-test and homogeneity of variance was assessed with Lev-
ene’s test. The intergroup differences for the four groups
were tested using one-way analysis of variance with post-
hoc Scheffe test or Kruskal-Wallis H-test with post-hoc
comparisons [38]. Differences between two groups were
analysed using the Mann-Whitney U-test, unpaired Stu-
dent t-test or χ2 test. Correlation analyses were performed
Poor insight into memory impairment in patients with Huntington disease
Neurologia i Neurochirurgia Polska 2012; 46, 4322
using Spearman rank correlation coefficients. A conven-
tional alpha of 0.05 was used in all the analyses.
Results
In terms of objective memory testing (AVLT), both
the sum of words recalled in trials I-V and the sum of
words recalled over the delay were significantly lower in
HD than in mild PD and cervical dystonia. The de layed
recognition score was lower in HD than in the other cli -
nical groups (Table 2).
The analysis of the intergroup differences in SRSMF
revealed that according to the caregivers the memory im -
pairment was greater in HD than in cervical dystonia,
which is in accordance with the AVLT results. How ever,
when patients’ ratings are considered, the only signifi-
cant difference was between advanced PD and mild PD.
Absolute average difference scores and underestimation
scores were significantly higher in HD than in cervical
dystonia. 
Subsequently, the correlation analysis of patients’ and
caregivers’ ratings with the selected measures from AVLT
was performed. In the HD group, there were no asso-
ciations between patients’ or caregivers’ ratings and AVLT
scores. In the advanced PD group, sum of words re called
in trials I-V correlated negatively both with the patients’
ratings (rho = –0.54; p < 0.05) and the caregivers’ rat-
ings (rho = –0.56; p < 0.01). In the mild PD group,
the percentage of words recalled after 10 minutes cor-
Patients with HD Patients with Patients with mild PD Patients with P-value for
N = 23 advanced PD N = 21 cervical dystonia differences
[A] N = 25 [C] N = 20 between 
[B] [D] groups 
Mini-Mental State Examination 26 27 28 28.5 0.02*
score [pts], median
AVLT – I-V trials [pts], 29.5 ± 8.33 38.2 ± 11.78 41.33 ± 12.65 44.60 ± 11.02 0.002**
mean ± SD A vs. C, A vs. D
AVLT – corrected recognition 9 14 13 13 0.0002*
[pts], median A vs. B, A vs. C, 
A vs. D
AVLT – delayed recall [pts], 5.52 ± 2.69 7.68 ± 3.24 8.67 ± 2.99 9.90 ± 3.68 0.002**
mean ± SD A vs. C, A vs. D
AVLT – delayed recall [%], 71.33 ± 21.70 79.39 ± 18.38 86.39 ± 17.39 87.21 ± 19.83 0.03**
mean ± SD
AVLT – delayed recognition [pts], 8 12 11 12 0.0019*
median A vs. B, A vs. C, 
A vs. D
SRSMF – patient’s ratings [pts], 68 68 60 62.5 0.03*
median B vs. C
SRSMF – caregiver’s ratings 69 64 61 60 0.009*
[pts], median A vs. D
SRSMF – patient-caregiver –2 5 0 2 0.047*
difference: raw score, median
SRSMF – average of absolute 0.67 0.56 0.39 0.39 0.04*
differences between patients and A vs. D
caregivers, median
SRSMF – underestimation score, 6 3 3 2 0.014*
median A vs. D
Table 2. The results of neuropsychological assessment and the questionnaire assessment of memory impairment severity in Huntington disease (HD), advanced Par-
kinson disease (PD), mild PD and cervical dystonia
SD – standard deviation; AVLT – Auditory Verbal Learning Test; SRSMF – Self-Rating Scale of Memory Function
*Kruskal-Wallis test with post-hoc comparisons
**one-way analysis of variance with post-hoc Scheffe test
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related negatively with the caregivers’ ratings (rho = –0.57;
p < 0.01). In the cervical dystonia group, the patients’
ratings correlated negatively with the sum of words re -
called in trials I-V (rho = –0.63; p < 0.01), corrected
immediate recognition score (rho = –0.45; p < 0.05) 
and sum of words recalled after the delay (rho = –0.48; 
p < 0.05). In the same group, the caregiver’s ratings cor-
related negatively with the sum of words recalled in 
trials I-V (rho = –0.72; p < 0.01), corrected immediate
recognition score (rho = –0.62; p < 0.01) and the sum
of words recalled after delay (rho = –0.54; p < 0.05). 
Subsequently, the correlation analysis of AADS and
US with MMSE, MADRS, disease duration in years,
UHDRS motor score and UHDRS independence scale
was performed for the HD group. AADS correlated 
with the UHDRS motor score (rho = 0.45; p < 0.05)
and UHDRS independence scale score (rho = –0.49;
p < 0.05). It means that greater symptom severity in 
HD was associated with more inadequate self-ratings 
of memory. Disease duration was associated with AADS
(rho = 0.53; p < 0.05). There were no associations bet -
ween self-awareness measures and MMSE or MADRS. 
Discussion
Data from the literature suggest that self-awareness
of memory impairment may be affected in HD, as in the
case of other domains. A few questions addressing mem-
ory were included in some of the previous questionnaire
studies [20,21,23], but they did not allow one to eval-
uate the self-awareness of memory impairment in HD,
as memory was not assessed as a separate component in
those studies. In a study by Ho et al. [23], the Dysexe-
cutive Questionnaire was used, in which some of the ques-
tions concern the executive component of memory. How-
 ever, the factor analysis did enable the disentangling of
the memory component. In none of the previous stud-
ies was the insight into memory impairment in HD speci-
fically analysed. Therefore, our study is the first one to
address the self-awareness of memory impairment in HD.
In our study, verbal learning and delayed recall were
similarly affected in HD and advanced PD, which is in
accordance with the literature on the relatively similar pro-
file of episodic memory impairment in HD and PD [16].
However, slightly more severe episodic memory impair-
ment in HD than in other clinical groups, as shown by
poorer recognition performance, cannot be attributed to
depressed mood, as mood differentiated between the two
PD groups, but not between HD and other clinical groups.
No associations were detected in HD between the ob -
jective memory testing results and the self-ratings of me -
mory. However, underestimation of memory impairment
was noted on the basis of patient-caregiver comparison,
which is in accordance with data on the deficient self-
awareness in HD in other motor and cognitive domains
[17-23].
Different causes of impaired insight in HD are hypo -
thesized: (1) cognitive: global cognitive impairment, me -
mory impairment, deficient monitoring-cognitive con-
trol, (2) emotional: avoidance coping, mood disturbance,
(3) disease-related: symptom severity and sensory de ficits
(in case of involuntary movements perception) [19]. In
the present study, impaired insight was associated with
greater disease severity, which is in accordance with the
progressive nature of the disorder [39].
Deficient self-awareness in HD had been frequently
associated with prefrontal pathology, but it was demon-
strated that orbitofrontal dysfunction is also present in
mild PD without dementia [40,41]. What is more, neu-
rodegeneration in HD does not affect frontal lobes in
a selective manner, as there is a growing body of evidence
on extra-fronto-striatal dysfunction even early in the course
of HD, especially in the posterior brain regions and 
within the corpus callosum [42-45]. Because of the lack
of neuroimaging data in our study, it does not add to the
knowledge about brain correlates of deficient self-awa -
reness in HD.
Notably, in HD not only the patients’ ratings but 
also the caregivers’ ratings did not correspond with the
objective memory assessment results. The HD caregivers’
did assess the patients’ memory capacity as inferior to that
of cervical dystonia patients. However, in contrast to all
the other clinical groups, in HD there was no associa-
tion between the objective assessment results and care-
givers’ ratings. This may imply that not only HD
patients, but also the caregivers may be biased in the sub-
jective memory ratings. Inadequate caregiver ratings may
be due to defence mechanisms or the poor awareness of
the specificity of memory impairment in HD. On the one
hand, memory impairment can be attributed to age (the
average in the HD group was 49.83 ± 11.12 years). On
the other hand, because of predominant motor disabil-
ity or psychiatric symptoms in the patients, the caregivers
may need to believe in the preserved cognitive functions
of their patients. Moreover, in Polish society memory
impairment is usually associated with Alzheimer disease,
while in HD the memory deficits are not only milder, but
also have a different specificity: poor spontaneous recall
with better recognition and cued recall [6,12,13,16]. 
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It may also contribute to the difficulties with interpretation
of memory problems by the caregivers.
Our study has several shortcomings. Firstly, the
groups were relatively small, albeit not smaller than in two
other studies addressing self-awareness in HD with clin-
ical comparison groups: with 9 HD patients [18] or 
23 HD patients [19]. Secondly, neuropsychological as -
sessment addressed only memory and it was not possible
to study the effect of other cognitive dysfunctions on the
self-awareness of deficits. What is more, only verbal learn-
ing was assessed, while the other aspects of memory (e.g.
verbal memory of structured material, visual memory) were
not tested. AVLT was chosen because it was used in pre-
vious studies with SRSMF [37,46] and due to the sen-
sitivity of verbal learning measures in subcortical demen-
tias. Lastly, as HD patients were treated with different
neuroleptics and other drugs, the effect of medication on
the self-awareness of symptoms could not be analysed due
to the heterogeneity of treatment regimens.
Due to the lack of medication that could address mem-
ory impairment in HD, the recognition of those deficits
does not influence the pharmacotherapy decisions.
However, it is crucial for the caregiver’s education and
counselling [47]. For instance, the diagnosis of signi ficant
memory impairment in HD justifies the supervision 
of medication taking by the caregiver. Therefore, simi-
lar studies are not only of cognitive but also of practical
importance. 
Conclusions
Insight into memory impairment is significantly com-
promised in HD. Poor self-awareness of memory im pair-
ment in HD is associated with longer disease duration
and greater disease severity.
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